Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Oncofertility w praktyce klin.
  • Obniżka
Substance Use Disorders

Substance Use Disorders

9780190920197
435,24 zł
391,72 zł Zniżka 43,52 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 391,72 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Substance Use Disorders provides an overview of substance misuse and addresses the neurobiology, pharmacotherapy, and behavioural therapy management of substance use disorders from a clinical perspective. Examining the opioid epidemic to frame its discussion of the epidemiology of substance misuse, this book explores common barriers that prevent the implementation of effective treatment. Chapters discuss various aspects of substance use disorders, particularly opioids,alcohol, cannabis, and cocaine, to inform better conceptualization and management of these conditions. Part of the Primer On Psychiatry series, this book will provide a solid foundation for residents and fellows in psychiatry and addiction medicine and can also be used in clinical practice.
Szczegóły produktu
OUP USA
89262
9780190920197
9780190920197

Opis

Rok wydania
2020
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
384
Wymiary (mm)
178 x 254
Waga (g)
703
  • Chapter 1: Epidemiology of Substance Use Disorders: Opioid Use Disorder Epidemic; Chapter 2: Epidemiology of Cannabis Use Disorder: Neural Substrates & Treatment; Chapter 3: Preclinical Models of Substance Use Disorder: Abuse Liability Assessment and Candidate Pharmacotherapy Evaluation; Chapter 4: Impulsivity and Drug-Seeking Behavior in Substance Misuse: A Preclinical Perspective; Chapter 5: Impulsivity and Cue Reactivity in Substance Misuse: Clinical Studies; Chapter 6: Stress and Substance Misuse; Chapter 7: Overview: Barriers and Advantages of Utilization of FDA Approved Medications for Substance Use Disorder; Chapter 8: Methadone for Opioid Use Disorder; Chapter 9: Use of Buprenorphine for the Treatment of Opioid Use Disorder; Chapter 10: Antagonist Treatment for Opioid Use Disorder: Development of Antagonist Treatment. Antagonists vs. Agonist Treatments Pros and Cons; Chapter 11: Pharmacotherapy for Opioid Use Disorders in Special Populations; Chapter 12: Pharmacology of Alcohol Use Disorder; Chapter 13: Pharmacotherapy for Smoking Cessation: Overview of Medications Including Over-the-Counter Nicotine Replacement Therapy, Bupropion and Varenicline; Chapter 14: What is Evidence Based Treatment?; Chapter 15: Evidence Based Behavioral Therapies for Substance Use Disorder; Chapter 16: Evidence Based Pharmacotherapy for Cocaine, Amphetamine, and Methamphetamine Use Disorder: Overview and History of Clinical Trials; Chapter 17: Evidence Based Pharmacotherapy for Alcohol Use Disorder; Chapter 18: Turn the Next Page: Envisioning the Future of Addiction Therapeutics;
Komentarze (0)

  • Często kupowane razem

    Brak dostępnych produktów